Smart Education in Ireland : MSD unveils €11.5m investment in Carlow biologics plant

Equipment upgrade for vaccines facility will also aid development of new cancer drug

The pharma company, which employs more than 2,000 people across its sites in Dublin, Carlow, Cork, Tipperary and Wicklow, made the announcement during a visit by the U S ambassador to Ireland, Kevin O’Malley.

The state-of-the-art 200,000sq ft biologics operation produces vaccines for customers across the world. It is also responsible for leading the company’s efforts in developing a new cancer treatment.

Jean-Albert Pittaluga, who runs the Carlow plant, said the investment reflected MSD’s ongoing commitment, to the town and to supporting “the growth and expansion of innovative product lines led by a highly skilled Irish workforce”.

“The production facilities here in Carlow are best in class internationally,” he said. “Through our continued focus on innovation and new product development, we look forward to growing our manufacturing output in Ireland and offering new treatment options to patients.”

Mr O’Malley said he had become aware of the “hotbed of innovation and talent that exists here in Ireland” since taking up his post.

To see such a substantial investment being made in growing and developing these innovations locally in Carlow, particularly in the area of human vaccination, is hugely encouraging,” he said.

"Ireland is emerging the best place to study nowadays...many students are selecting Ireland because the country offers many good reasons which no other country till now offers", says Mr. Deepak, Education Manager, Career XL Services..


Click here